Zhejiang Yatai Pharmaceutical (002370.SZ) subsidiary Yatai Xinghao obtains pharmaceutical business license.
Zhejiang Yatai Pharmaceutical (002370.SZ) announced that its controlled subsidiary Zhejiang Yatai Xinghao Pharmaceutical Co., Ltd. ("Yatai Xinghao") recently obtained the Pharmaceutical Business License issued by the Zhejiang Provincial Medical Products Administration. Business scope: Chinese patent medicines, chemical drugs***.
Zhejiang Yatai Pharmaceutical (002370.SZ) announced that its controlled subsidiary Zhejiang Yatai Xinghao Pharmaceutical Co., Ltd. ("Yatai Xinghao") recently obtained the Pharmaceutical Business License issued by the Zhejiang Provincial Medical Products Administration. Business scope: Chinese patent medicines, chemical drugs***.
The controlled subsidiary Yatai Xinghao's acquisition of the Pharmaceutical Business License this time marks that it has the qualification to legally carry out pharmaceutical wholesale and distribution business, which helps improve the company's layout in the pharmaceutical industry chain and has a certain promoting effect on the company's overall business development, but will not have a material impact on the company's performance in the short term.
Related Articles
Anhui Honglu Steel Construction (002541.SZ) subsidiary signs major operating contract, total amount tentatively RMB248 million
Reportedly, SpaceX (SPCX.US) is attempting "de-NVIDIA Corporation-ization" at the rack level: developing the Kessel rack to bypass the L6 compute board and buy only chips.
Sinomine Resource Group (002738.SZ) received a commitment from its controlling shareholder, actual controller, and their concerted parties not to reduce their shareholdings.
Anhui Honglu Steel Construction (002541.SZ) subsidiary signs major operating contract, total amount tentatively RMB248 million
Reportedly, SpaceX (SPCX.US) is attempting "de-NVIDIA Corporation-ization" at the rack level: developing the Kessel rack to bypass the L6 compute board and buy only chips.
Sinomine Resource Group (002738.SZ) received a commitment from its controlling shareholder, actual controller, and their concerted parties not to reduce their shareholdings.
